HAVE A SPECIALIZED PROJECT?
Connect with us to learn about custom solutions to meet your unique needs.
OUR CO-PILOT
Built for the hardest problems in biologics discovery
Traditional discovery workflows often fail to identify potential developability challenges early enough to prevent costly failures.
EMLy Co-pilot surfaces development challenges, explores alternatives, and advances the highest-quality lead candidates faster.
See how EMLy helps you design and optimise biologics with real-time computational feedback.
SINGLE AGENTIC PLATFORM
How EMLy Co-pilot works
Say goodbye to juggling a dozen disparate computational tools and datasets. EMLy Co-pilot’s single agentic platform condenses time-consuming workflows into minutes of intuitive, guided interaction while feeling more like a scientifically fluent partner rather than a machine.
Start with your scientific question
Describe targets, constraints, or hypotheses just as you would to a collaborator
Explore and iterate
Generate, compare, and refine variants in minutes
Evaluate and decide
Get higher-quality, more developable lead candidates
OUR CAPABILITIES
What you can do with EMLy Co-pilot
Decode, predict, and design candidates through a simple chat interface. With EMLy handles the complex integration of multiple tools and datasets, creating the next life-changing immunotherapy is as easy as clicking 'search'.
The result is higher-quality, more developable lead candidates.
Design & optimise biologic candidates
Explore antibodies, T cell receptors, bi-specifics, and VHH fragments across multiple design paths
Identify liabilities early
Evaluate stability, expression, aggregation risk, and manufacturability before costly downstream work begins.
Compare variants with confidence
Produce and assess variants side by side to prioritise the best candidates.
Integrate IP insight into discovery
Evaluate novelty and Freedom to Operate alongside scientific decisions, not after the fact.
REAL RESULTS
See EMLy in action
Across industry collaborations, EMLy has resolved developability bottlenecks, improved expression and stability, and delivered high-affinity candidates in months, not years.
LOOKING FORWARD
Future integrations for EMLy Co-pilot
EMLy Co-pilot marks the beginning of a new era in therapeutic design. Upcoming releases will incorporate our proprietary workflows:
-
Functional immune discovery for rapid lead identification
-
Bespoke antibody library design
-
In silico co-complex prediction
Request early access to our
program or find out more.
Join us in our journey as we explore how Etcembly with EMLy Co-pilot is transforming the landscape of drug discovery with AI-driven solutions.
A multi-modality platform
As solution architects, we recognise that there is no one-size-fits-all approach to protein design. We must uniquely tailor each biologic to meet specific therapeutic needs. That's why we made EMLy's protein language models to be both modality- and disease-agnostic.